Skip to main content
. Author manuscript; available in PMC: 2019 Oct 24.
Published in final edited form as: Mol Genet Genomics. 2019 Apr 17;294(4):1059–1071. doi: 10.1007/s00438-019-01567-7

Table 3.

Demographical and clinical characteristics of the study populations for VT

GeneID VT Cohort 1 VT Cohort 2
Cases
n = 299		 Controls
n = 981		 Cases
n = 270		 Controls
n = 639
Age (mean ± SD years) 52 ± 19.4 51 ± 8.4 58 ± 13.5 56 ± 11.0
Sex, male n (%) 142 (47.5) 604 (61.6) 204 (75.6) 544 (85.1)
Idiopathic VT (IVT) 180 (60.2) N/A 118 (43.7) N/A
Hypertension n (%) 203 (42.9) 63 (6.4) 116 (43) 247 (38.7)
CAD n (%) 222 (47.5) N/A 142 (52.6) 357 (55.9)
Diabetes n (%) 82 (17.3) N/A 59 (21.9) 112 (17.5)

Data are shown as mean ± standard deviation (SD) for quantitative variables and percent (%) for qualitative variables; Hypertension was defined as a systolic blood pressure of ≧ 140 mmHg or a diastolic blood pressure of ≧ 90 mmHg. Diabetes was defined as ongoing therapy of diabetes or a fasting plasma glucose level of ≥ 7.0 mmol/L; IVT, VT without any structural heart disease, coronary artery disease and myocardial infarction, cardiomyopathies, valvular disease, rheumatic heart disease, hypertension, and heart failure

CAD coronary artery disease